| TITRE |
Étude observationnelle rétrospective pour évaluer l’imagerie et la gestion des patients atteints d’un cancer de la prostate résistant à la castration |
| PROTOCOLE ID |
AMGEN 20150126 |
| CLINICAL TRIAL.gov ID |
|
| TYPE(S) DE CANCER |
Prostate |
| PHASE |
Autres |
| TYPE D'ÉTUDE |
|
| INSTITUTION |
CENTRE UNIVERSITAIRE DE SANTE MCGILL
1001 boul. Décarie
|
| VILLE |
Montréal
|
| INVESTIGATEUR(RICE) PRINCIPAL(E) |
Armen Aprikian
|
| COORDONATEUR(RICE) |
Maria Simona Grigorie
514-934-1934 poste 35160
|
| STATUT |
Fermé
|
| CRITÈRES D'ÉLIGIBILITÉ |
(EN)
- Men diagnosed with castration-resistant prostate cancer, defined as a recorded PSA
- value of ≥2 ng/mL despite ongoing androgen deprivation therapy (ADT)
- Patient has completed at least one follow-up clinic visit subsequent to the development of castration-resistance (the date of this clinic visit defines the index date)
- Age ≥18 years at index date
- Patient can have prior or current evidence of detectable bone or visceral metastasis(es) and MUST have completed at least one additional follow-up visit subsequent to the identification of bone/visceral metastases and the patient’s chart contains details of this follow-up visit
|
| CRITÈRES D'EXCLUSION |
(EN)
- Patient had evidence of detectable bone or visceral metastasis(es) at index date
- Patient has received investigational agent(s) or completed investigational procedures as part of a non-metastatic CRPC clinical study protocol
|
